BIOCRYST PHARMACEUTICALS INC (BCRX) Stock Analyst Ratings
USA - NASDAQ:BCRX - US09058V1035 - Common Stock
7.02 USD
-0.13 (-1.82%)
7.03 USD
+0.01 (+0.14%)
ChartMill assigns a Buy % Consensus number of 84% to BCRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.99. This target is 156.26% above the current price.
BCRX was analyzed by 17 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BCRX.
In the previous month the buy percentage consensus was at a similar level.
BCRX was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-04 | Needham | Maintains | Buy -> Buy |
| 2025-07-01 | B of A Securities | Maintains | Buy -> Buy |
| 2025-06-30 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-06-30 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-06-27 | Needham | Reiterate | Buy -> Buy |
| 2025-06-25 | Needham | Reiterate | Buy -> Buy |
| 2025-05-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-06 | Needham | Maintains | Buy -> Buy |
| 2025-05-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-29 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-04-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-04-10 | Needham | Reiterate | Buy -> Buy |
| 2025-03-03 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-25 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-31 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-13 | Needham | Maintains | Buy -> Buy |
| 2025-01-13 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-11-05 | Needham | Reiterate | Buy -> Buy |
| 2024-11-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-06 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-07 | Needham | Reiterate | Buy -> Buy |